LISATA THERAPEUTICS, INC. Logo

LISATA THERAPEUTICS, INC.

Develops therapies to enhance anti-cancer drug delivery to solid tumors.

LSTA | US

Overview

Corporate Details

ISIN(s):
US1280583022 (+1 more)
LEI:
Country:
United States of America
Address:
110 ALLEN ROAD, 7920 BASKING RIDGE

Description

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 17:16
10-Q
English 1.9 MB
2025-11-06 17:10
8-K
English 17.4 MB
2025-10-14 18:02
8-K
English 15.4 MB
2025-10-08 17:12
8-K
English 58.4 KB
2025-08-07 18:13
10-Q
English 26.4 MB
2025-08-07 18:09
8-K
English 15.9 MB
2025-07-15 10:00
8-K
English 759.7 KB
2025-06-26 10:38
8-K
English 17.8 MB
2025-06-17 11:13
8-K
English 14.7 MB
2025-06-13 18:02
8-K
English 24.5 MB
2025-06-10 18:03
8-K
English 57.7 KB
2025-05-08 18:14
10-Q
English 2.1 MB
2025-05-08 18:07
8-K
English 12.7 MB
2025-04-25 18:12
DEFA14A
English 12.6 MB
2025-04-25 18:10
DEF 14A
English 16.8 MB

Automate Your Workflow. Get a real-time feed of all LISATA THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for LISATA THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for LISATA THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.